Previous Article | Next Article ![]()
Infection and Immunity, January 2006, p. 798-801, Vol. 74, No. 1
0019-9567/06/$08.00+0 doi:10.1128/IAI.74.1.798-801.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
and
Preethi V. Udagama-Randeniya1*
Department of Zoology, Faculty of Science, University of Colombo, Colombo 3, Sri Lanka,1 Malaria Research Unit, Department of Parasitology, Faculty of Medicine, University of Colombo, Colombo 8, Sri Lanka,2 Department of Parasitology, Biomedical Primate Research Centre, 2280 GH Rijswijk, The Netherlands3
Received 17 July 2004/ Returned for modification 24 August 2004/ Accepted 20 October 2005
Plasmodium vivax apical membrane antigen 1, an important malaria vaccine candidate, was immunogenic during natural malaria infections in Sri Lanka, where low transmission and unstable malaria conditions prevail. Antibody prevalence increased with exposure in areas where malaria was or was not endemic. A marked isotype switch to cytophilic (immunoglobulin G1 [IgG1]/IgG3) antibodies was evident with increasing exposure exclusively in residents from areas of endemicity.
Present address: Institute of Biochemistry, Molecular Biology & Biotechnology, University of Colombo, Colombo 3, Sri Lanka.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»